Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T01:34:51.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A notification banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:34:35.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:13:42.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T01:42:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, indicating access to the content is blocked. This replaces the typical study details with an access-denied notice rather than updating core content.
    Difference
    23%
    Check dated 2026-09-20T00:43:50.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study page text remains unchanged. Observed differences appear to be visual/layout updates that do not affect the core study details or results.
    Difference
    0.1%
    Check dated 2026-09-12T23:50:44.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.